Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF – Get Free Report) was the target of a significant decrease in short interest during the month of September. As of September 15th, there was short interest totaling 10,416 shares, a decrease of 66.5% from the August 31st total of 31,081 shares. Based on an average daily trading volume, of 6,751 shares, the short-interest ratio is presently 1.5 days.
Wall Street Analysts Forecast Growth
A number of equities analysts recently issued reports on the company. Royal Bank Of Canada raised Fisher & Paykel Healthcare from a “sector perform” rating to an “outperform” rating in a report on Tuesday, September 15th. Citigroup raised Fisher & Paykel Healthcare to a “buy” rating in a research note on Thursday, September 10th. Two analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company has a consensus rating of “Buy”.
Get Our Latest Report on FSPKF
Fisher & Paykel Healthcare Price Performance
Fisher & Paykel Healthcare Company Profile
Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical device company that develops, manufactures and markets products for respiratory care, acute care and the treatment of obstructive sleep apnea. The company’s offerings are designed for use in hospitals, intensive care units, operating rooms and homes.
Its product portfolio includes respiratory humidification systems, nasal high-flow therapy systems, noninvasive ventilation equipment, continuous positive airway pressure (CPAP) and bilevel masks, neonatal respiratory care products, and related consumables and accessories.
Further Reading
- Five stocks we like better than Fisher & Paykel Healthcare
- Rocket Lab Bounces Off Its Lows—What’s Behind the Move?
- NVIDIA Just Turned AI Safety Into a Spending Story and These 3 Stocks Benefit
- Why SpaceX Investors Should Look Past Starship’s Fiery Splashdown
- Meta’s Muse Is Taking Aim at E-Commerce, But Amazon Isn’t Playing Along
Receive News & Ratings for Fisher & Paykel Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fisher & Paykel Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
